FDA Inspection 760034 — Biomat USA Inc

Biomat USA Inc — FEI 2077878

The FDA completed an inspection of Biomat USA Inc on Dec 22, 2011 in Glendale, AZ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 22, 2011
Fiscal Year
2012
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Glendale, AZ (United States)

Citations

IDCFRDescription
7621 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs